Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Oct;66(4):427-9.
doi: 10.1111/j.1365-2125.2008.03293.x.

Prediction and reverse prediction in therapeutics and toxicology

Editorial

Prediction and reverse prediction in therapeutics and toxicology

J M Ritter. Br J Clin Pharmacol. 2008 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • Post-mortem clinical pharmacology.
    Ferner RE. Ferner RE. Br J Clin Pharmacol. 2008 Oct;66(4):430-43. doi: 10.1111/j.1365-2125.2008.03231.x. Epub 2008 May 29. Br J Clin Pharmacol. 2008. PMID: 18637886 Free PMC article. Review.
  • Maraviroc: in vitro assessment of drug-drug interaction potential.
    Hyland R, Dickins M, Collins C, Jones H, Jones B. Hyland R, et al. Br J Clin Pharmacol. 2008 Oct;66(4):498-507. doi: 10.1111/j.1365-2125.2008.03198.x. Epub 2008 Apr 10. Br J Clin Pharmacol. 2008. PMID: 18647303 Free PMC article.

References

    1. Joannides R, Moore N, Iacob M, Compagnon P, Lerebours G, Menard J-F, Thuillez C. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol. 2006;61:127–37. - PMC - PubMed
    1. Resch U, Tatzber F, Budinsky A, Sinzinger H. Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy. Br J Clin Pharmacol. 2006;61:262–74. - PMC - PubMed
    1. Whale CI, Sovani MP, Mortimer K, Oborne J, Cooper S, Harrison TW, Tattersfield AE. Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease. Br J Clin Pharmacol. 2006;62:153–7. - PMC - PubMed
    1. Pathak A, Velez-Roa S, Xhaët O, Najem B, van de Borne P. Dose-dependent effect of Dobutamine on chemoreflex activity In healthy volunteers. Br J Clin Pharmacol. 2006;62:272–9. - PMC - PubMed
    1. Salgado-Pineta P, Delaveau P, Falcon C, Blin O. Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study. Br J Clin Pharmacol. 2006;62:546–51. - PMC - PubMed

Substances